Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder

by palligoelme@gmail.com | Jun 23, 2025 | Clinical Trials

​ Conditions: Neuromyelitis Optica Spectrum Disorder (NMOSD) Sponsors: Samsung Medical Center Completed Conditions: Neuromyelitis Optica Spectrum Disorder (NMOSD) Sponsors: Samsung Medical Center Completed 

A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors

by palligoelme@gmail.com | Jun 23, 2025 | Clinical Trials

​ Conditions: Advanced Malignant Tumors Interventions: Drug: SSGJ-612 Sponsors: Shenyang Sunshine Pharmaceutical Co., LTD. Not yet recruiting Conditions: Advanced Malignant Tumors Interventions: Drug: SSGJ-612 Sponsors: Shenyang Sunshine Pharmaceutical Co., LTD. Not...

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )

by palligoelme@gmail.com | Jun 23, 2025 | Clinical Trials

​ Conditions: B-Cell Non-Hodgkin Lymphoma Interventions: Drug: CAR T cells Sponsors: Qian Wenbin; Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting Conditions: B-Cell Non-Hodgkin Lymphoma Interventions: Drug: CAR T cells Sponsors:...

Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)

by palligoelme@gmail.com | Jun 19, 2025 | Clinical Trials

​ Conditions: Alcohol Use Disorder Interventions: Drug: Intravenous Ethanol; Drug: 18F-PF-06445974 Sponsors: National Institute of Mental Health (NIMH) Recruiting Conditions: Alcohol Use Disorder Interventions: Drug: Intravenous Ethanol; Drug: 18F-PF-06445974...

ALERT-ED: Awareness and Linkage to Resources for At-Risk Emergency Department Patients

by palligoelme@gmail.com | Jun 19, 2025 | Clinical Trials

​ Conditions: High Fall Risk Interventions: Behavioral: ALERT-ED Sponsors: University of Colorado, Denver Not yet recruiting Conditions: High Fall Risk Interventions: Behavioral: ALERT-ED Sponsors: University of Colorado, Denver Not yet...